Literature DB >> 28429105

Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas.

K A Rubina1, V Yu Sysoeva2, E I Zagorujko3, Z I Tsokolaeva3, M I Kurdina2, Ye V Parfyonova3, V A Tkachuk2,3.   

Abstract

There is substantial evidence implicating the urokinase system in tissue remodeling during neo-vascularization, inflammation, tumor invasion, and metastasis. Regulated degradation of the extracellular matrix at the leading edge of migrating cells, mediated by uPA and uPAR, is required for tissue remodeling, invasiveness, and angiogenesis. Psoriasis and basal cell carcinoma (BCC) are the most common skin diseases. Pathogenesis of both of them is associated with keratinocyte hyperproliferation, inflammatory cell migration, and angiogenesis-processes in which the plasminogen system (uPA, uPAR, tPA, and PAI-1) plays a crucial role. In the present study, the comparative analysis of uPA, uPAR, tPA, and PAI-1 expression in the normal skin, in the biopsies of patients with psoriasis vulgaris, and BCC was carried out. uPA, uPAR, and PAI-1 expression was up-regulated in the epidermis of psoriatic skin and in tumor cells in BCC. Increased uPAR expression was detected in the derma of psoriatic lesions and in the stroma surrounding tumor cells in BCC. Increased expression of uPA in epidermal cells in psoriasis and in tumor cells in BCC suggests an important role of the uPA system for aggressively proliferating and invading cells of epidermal origin. A possible activation of the stroma, as a result of uPA-uPAR interaction between tumor cells and the surrounding stroma, is suggested.

Entities:  

Keywords:  Basal cell carcinoma; Psoriasis; Urokinase; Urokinase receptor

Mesh:

Substances:

Year:  2017        PMID: 28429105     DOI: 10.1007/s00403-017-1738-z

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

1.  UPAR silencing reveals its role in neuroblastoma.

Authors:  Natalia Kalinina
Journal:  Oncotarget       Date:  2018-07-27

2.  Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Wen-Jing Liu; Li Zhou; Zhi-Yong Liang; Wei-Xun Zhou; Lei You; Tai-Ping Zhang; Yu-Pei Zhao
Journal:  Chin Med J (Engl)       Date:  2018-12-20       Impact factor: 2.628

Review 3.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

4.  PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.

Authors:  Sandra Muñoz-Galván; Maria Rivero; Javier Peinado-Serrano; Julia Martinez-Pérez; M C Fernández-Fernández; María José Ortiz; José M García-Heredia; Amancio Carnero
Journal:  Cells       Date:  2020-04-25       Impact factor: 6.600

Review 5.  Aberrant Factors of Fibrinolysis and Coagulation in Pancreatic Cancer.

Authors:  Lianghua Fang; Qing Xu; Jun Qian; Jin-Yong Zhou
Journal:  Onco Targets Ther       Date:  2021-01-06       Impact factor: 4.147

Review 6.  Adipokines in the Skin and in Dermatological Diseases.

Authors:  Dóra Kovács; Fruzsina Fazekas; Attila Oláh; Dániel Törőcsik
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

Review 7.  Molecular Targets in Hepatocarcinogenesis and Implications for Therapy.

Authors:  Meng-Yu Wu; Giuo-Teng Yiang; Pei-Wen Cheng; Pei-Yi Chu; Chia-Jung Li
Journal:  J Clin Med       Date:  2018-08-13       Impact factor: 4.241

8.  CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation.

Authors:  Karina D Rysenkova; Ekaterina V Semina; Maxim N Karagyaur; Anna A Shmakova; Daniyar T Dyikanov; Petr A Vasiluev; Yury P Rubtsov; Kseniya A Rubina; Vsevolod A Tkachuk
Journal:  Oncotarget       Date:  2018-06-29

9.  Enhanced Wound Healing- and Inflammasome-Associated Gene Expression in TNFAIP3-Interacting Protein 1- (TNIP1-) Deficient HaCaT Keratinocytes Parallels Reduced Reepithelialization.

Authors:  Rambon Shamilov; Tyler W Ackley; Brian J Aneskievich
Journal:  Mediators Inflamm       Date:  2020-04-21       Impact factor: 4.711

Review 10.  Therapeutics targeting the fibrinolytic system.

Authors:  Haili Lin; Luning Xu; Shujuan Yu; Wanjin Hong; Mingdong Huang; Peng Xu
Journal:  Exp Mol Med       Date:  2020-03-09       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.